Misaki Homma

411 total citations
7 papers, 258 citations indexed

About

Misaki Homma is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Misaki Homma has authored 7 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Epidemiology. Recurrent topics in Misaki Homma's work include Cancer therapeutics and mechanisms (3 papers), Synthesis and Reactivity of Heterocycles (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Misaki Homma is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Synthesis and Reactivity of Heterocycles (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Misaki Homma collaborates with scholars based in Japan and United States. Misaki Homma's co-authors include Nobuo Cho, Megumu Takahashi, Mayu Sugiyama, Yoshiyuki Tsujihata, Atsushi Miyawaki, Hiroyuki Katayama, Koji Nagasawa, Ryoko Ando, Hiroshi Hama and Hiroshi Kurokawa and has published in prestigious journals such as Cell, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Misaki Homma

7 papers receiving 254 citations

Peers

Misaki Homma

MB

EPIDE

OC

ONCOL

PHYSI

Eli Schuman United States

Weizhen Gao China

Nikhil Gadewal India

Elliot D. Mock Netherlands

Mark I. Kemp United Kingdom

Hanjie Jiang United States

Christine Harman United States

Anna D. Cunningham United States

Yong Chu China

Christopher Foley United States

Eli Schuman United States

Misaki Homma

303 ×2.1

MB

55 ×0.8

EPIDE

40 ×0.8

OC

49 ×1.3

ONCOL

46 ×1.5

PHYSI

Citations per year, relative to Misaki Homma Misaki Homma (= 1×) peers Eli Schuman

Countries citing papers authored by Misaki Homma

Since Specialization

Citations

This map shows the geographic impact of Misaki Homma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misaki Homma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misaki Homma more than expected).

Fields of papers citing papers by Misaki Homma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misaki Homma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misaki Homma. The network helps show where Misaki Homma may publish in the future.

Co-authorship network of co-authors of Misaki Homma

This figure shows the co-authorship network connecting the top 25 collaborators of Misaki Homma. A scholar is included among the top collaborators of Misaki Homma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misaki Homma. Misaki Homma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Naito, Yusuke, et al.. (2023). Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells. SLAS DISCOVERY. 28(7). 344–349. 5 indexed citations

2.

Kurasawa, Osamu, T. Miyazaki, Misaki Homma, et al.. (2020). Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. Journal of Medicinal Chemistry. 63(3). 1084–1104. 16 indexed citations

3.

Katayama, Hiroyuki, Hiroshi Hama, Koji Nagasawa, et al.. (2020). Visualizing and Modulating Mitophagy for Therapeutic Studies of Neurodegeneration. Cell. 181(5). 1176–1187.e16. 120 indexed citations

4.

Kurasawa, Osamu, Yuya Oguro, T. Miyazaki, et al.. (2017). Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones. Bioorganic & Medicinal Chemistry. 25(7). 2133–2147. 14 indexed citations

5.

Kurasawa, Osamu, Misaki Homma, Yuya Oguro, et al.. (2017). 2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase. Bioorganic & Medicinal Chemistry. 25(14). 3658–3670. 10 indexed citations

6.

Sameshima, Tomoya, Ikuo Miyahisa, Misaki Homma, et al.. (2014). A simple and widely applicable hit validation strategy for protein–protein interaction inhibitors based on a quantitative ligand displacement assay. Bioorganic & Medicinal Chemistry Letters. 24(24). 5836–5839. 2 indexed citations

7.

Tanaka, Yuta, Katsuji Aikawa, Goushi Nishida, et al.. (2013). Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins. Journal of Medicinal Chemistry. 56(23). 9635–9645. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact